Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My quessis that someone is making a large 9.9% stake in LXRP and it's probably Aurora Cannabis. JMHO
And NASDAQ doesn't want to list MJ companies because it's illegal federally.
So the warrant holder can exercise them at a much higher share price in the future.
It's a start for sure, but the greenhouse business seems to be highly competitive. Many companies offer state of the art, fully automated, blackout greenhouses.
Aurora is building the world's largest at the Edmonton airport and they chose a Dutch manufacturer as the Dutch have great experience growing under glass, probably a lot more than Greengro.
Month end clearance sale on now till Friday!
Oral lipid-based drug delivery systems – an overview
http://www.sciencedirect.com/science/article/pii/S2211383513000919
Crash Fatality Rates After Recreational Marijuana Legalization
https://www.ncbi.nlm.nih.gov/pubmed/28640679
CannaTech 2017 - Oral Bio-availability: Cannabinoid Delivery System - Doron Friedman
Looks like a big bullish Hammer Candlestick on the chart today along with above-average volume.
Monday should be very interesting!
Aurora + Hempco+ Lexaria
Aurora is buying an interest in Hempco which has a licensing agreement with Lexaria.
https://technical420.com/cannabis-article/aurora-cannabis-one-step-away-becoming-cbd-leader
Updated Website
https://www.lexariaenergy.com/
Canadians, eh!
Well you'd better watch out or we'll repeal and replace NAFTA. LOL
Well, what is he telling you, do share!
Save us a phone call.
I think others see what I do as the bids are starting to pour in. Higher prices are just ahead!
2017-09-28 08:30 ET - News Release
American Cannabis Company, Inc. Announces Successful Submission of Licensed Producer (LP) Application Materials For Its Active New Brunswick Client
DENVER, CO--(Marketwired - Sep 28, 2017) - American Cannabis Company, Inc. (OTCQB: AMMJ) (the "Company"), a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis industry, today announced that its active client in New Brunswick has successfully submitted application materials and supporting documents for the purpose of acquiring business licenses to operate within the newly founded medical cannabis program that is to be regulated by the province and the Canadian government.
This client will be constructing a custom 63,000 square foot warehouse featuring state-of-the-art cultivation and extraction technologies with a focus on lean manufacturing principles. ACC's client will also be placing a 50,000 square foot greenhouse on the roof of the warehouse, expanding the firm's overall output potential as they look to service the demand of the medical market as well as ramp-up and prepare for licensure and sales for Canada's upcoming 2018 recreational market.
Terry Buffalo, CEO of American Cannabis Company, commented: "We are very pleased to be working with such a determined and dedicated client who wants to see their businesses truly succeed. Canada is full of business opportunity for our firm, and we cannot be happier to be providing services to what will soon be a top-tier producer in the space."
About American Cannabis Company, Inc.
American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis industry. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. American Cannabis Company also developed and owns a portfolio of branded products including: The Satchel™, SoHum Living Soils™, The Cultivation Cube™ and The High Density Cultivation System™. We also design and provide other industry specific custom product solutions. The building and development of our brands and product suite is based on our Geoponics Philosophy, "the art and science of agriculture in soil."
For more information, please visit:
www.americancannabisconsulting.com
www.americancannabiscompanyinc.com
www.sohumsoils.com
Forward Looking Statements
This news release contains "forward-looking statements" which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "expect", "project", "plan", or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.
Contact:
American Cannabis Company, Inc.
IR@americancannabisconsulting.com
303-974-4770
© 2017 Canjex Publishing Ltd. All rights reserved.
Exactly Presley. Also, why wait for an hour to sometimes 2 hours for Viagra's desired effect when the opportunity presents itself immediately. Shall we say 15 to 20 minutes, with LXRP technology.
Technically the chart looks very bullish we've just broken out from the right shoulder of a reverse head and shoulder bottom, and pierced overhead resistance at .425, 200 and 50 MA are in bullish allignment and volume is bullish, lots of room for RSI and MACD to run higher. It's a screaming buy!
Patent Expiration
If you're a big pharma with a blockbuster drug soon to go off patent, and you combine your blockbuster with LXRP's delivery technology, do you then have a new substance which would qualify for a patent extension?
Things are looking good, revenue increasing year after year and business is expanding into new technologies and jurisdictions. Poised to cash in on the MJ boom.
Introducing New Technologies. The Company is currently working on a highly innovative real estate development project in Canada with a leading greenhouse manufacturer to build a first and one-of-a-kind marijuana cultivation facility, which will be introduced to the marijuana industry via this project. The custom design features a 64,600-square foot indoor cultivation and processing facility with a 46,368-square foot greenhouse on top of the building for a total of 110,968 square feet dedicated to canopy and supporting functions. Additionally, the indoor cultivation utilizes American Cannabis Company's proprietary, vertical cultivation solution, the High Density Cultivation System™ ("HDCS™"). HDCS applies the principles of lean manufacturing to maximize the amount of usable square feet and horticulture production yields in the facility.
International Expansion. While the Company has continued to increase its footprint and client engagements in the United States (U.S.) and Canada, it is currently exploring new opportunities and partnerships in international markets, including Europe, the Middle East, South America, the United Kingdom (U.K.), South Africa, and Jamaica.
Interesting action indeed. It was a pretty good tree shaking by the bears with the bulls patiently picking up the falling fruit.
Chart still looks bullish after today's close with support tested at .82 and overhead resistance holding at $1.20. A strong move through $1.20 would be very bullish indeed, but the more likely scenario is that we trade sideways for the rest of the week as the overbought situation continues to unwind.
Best of luck.
Yes revenue up, but still a large loss and further increase in shares O/S
No sales of large commercial greenhouses despite the announcement of deals.
Have they ever sold any large commercial greenhouses ever?
Technically any close over $1.00 would be very Bullish.
Have to agree never any pump with AMMJ, they're too focused on growing the company for the benefit of shareholders.
Just a normal correction after a parabolic rise which put us in extreme overbought territory on chart (RSI). You could have bought this puppy for .50 just over a month ago.
The Bears have crapped and they Bulls are picking up all their droppings ahead of the next upswing.
So we lost $1,196,000 in the last quarter. So -1,196,000 x 1000 = -1,196,000,000.
We lost over a billion in the last quarter?
Must have gone to Haas' salary and benefits. LOL
Financials Again,thanks to Morgzack.
https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12243759
Have to agree $$$ really do matter. It's a business after all, here to make money and the more money you make/or potential to make same, the better the chart will become.
Another good move today on strong volume. AMMJ shows that the better companies can make a good profit in this industry.
I expect AMMJ to be a consolidator or consolidated in this business. Big money has been circling this industry for some time and the best companies are going to be snapped up.
The outlook is bright.
Doesn't look good for GRNH.
I should have put more into AMMJ American Cannabis, it's doubled up in the last 45 days!
Definitely looks like a perfectly formed cup and handle to me, with a big hammer candlestick on Friday.
Chart has real upside potential.
I'm glad there was no news today because you never see good news on a Friday.
I'm patient, the results will be out as soon as the CPA has finished reviewing them.
I think most people agree, we want to see audited financials so let's give him a chance to finish.
The company is in negotiation with at least four large pharmaceutical companies to license its technology
Regulation Forcing Drug and Cigarette Companies to Be More Responsible is Great News for Lexaria (LXRP), says CEO
In an interview with Stock Day, CEO Chris Bunka of Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) discussed the company’s recent achievements and its plans for the near future. Revenues are climbing, exceeding, so far in 2017, the total for all of 2016, and the potential for further increases is imminent. The company is in negotiation with at least four large pharmaceutical companies to license its technology. The smallest of these could increase revenues by $1 million; the largest could increase revenues by much, much more, according to Bunka. Getting any of these deals signed will boost the bottom line almost as much as they would raise revenues. Lexaria will be employing a lucrative licensing model that is likely to yield 90-100% of revenues as profit. The company expects to have its first major agreement wrapped up by the end of the year.
Apart from attracting the attention of big pharma, Lexaria has been working with the National Research Council (NRC) of Canada, an agency of the Canadian federal government, to explore the effects of its technology. The company has developed technology that allows non-psychoactive cannabinoids, vitamins, non-steroid anti-inflammatory drugs (NSAIDs) and nicotine to be absorbed at much higher rates. Lexaria’s superior delivery system offers the promise of potentially reducing required doses of these substances, since less of them goes to waste. The technology also speeds up delivery. It can deliver payload molecules to the bloodstream in 15-25 minutes, as opposed to 60-90 minutes for current methods, and is already in use in a number of consumer products.
Lexaria recently raised $4 million in capital. The company intends to spend part of the proceeds in setting up an R&D program for nicotine. The initiative comes at an opportune time. In August, the FDA announced “a new comprehensive plan for tobacco and nicotine regulation that will serve as a multi-year roadmap to better protect kids and significantly reduce tobacco-related disease and death” (http://nnw.fm/hLdm6). The agency plans to stimulate public dialogue on lowering nicotine levels in combustible cigarettes to non-addictive levels. This is good news for Lexaria, which is hoping its technology can provide a delivery method for nicotine that is safer than smoking. As its CEO has remarked, “Regulation is great news for Lexaria.”
The interview can be heard at http://nnw.fm/9QqQ8
For more information, visit the company’s website at www.LexariaEnergy.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Read more at http://www.stockhouse.com/companies/bullboard?symbol=lxrp&postid=26580364#IABxlkXuEEJe0ehF.99
Well that was a great day, the highest daily volume since the third week of Feb.
Remember, volume precedes price rise!
https://technical420.com/cannabis-article/5-cannabis-stocks-should-be-your-watchlist-0
Could this article be the cause of today's increased volume?
The good thing is that a CPA is reviewing the figures. Audited?
Results probably won't be released until Monday the 21st.
FDA Tobacco Regs
https://www.reuters.com/article/us-fda-tobacco-regulation-idUSKBN1AD1VW
With the FDA set to lower the allowable level of nicotine in cigs. more attention may focus on companies such as lexaria who have alternate delivery methods for nicotine.
One needs to remember that revenue from ancillary products was way down in the latest financials. If they keep dropping the only thing left will be consulting income.
One large block of 1,144,000 shares went through this am in one trade almost doubling the volume to over 3 million.